However it appears to be forming a double top in a potential short trade setup on the two hour chart.
The K/D crossover on the hot RSI oscillator provides confirmation.
Short Sale Volume is rising in the past two days.
Findamentals - LXRX has a new medication for heart failure a common medical problem with a massive market It recently launched a public offering to raise capital to fund general operations and in doing so diluted the share holders. The good news is it is unlikely to do another in the near term.
An entry would be at the current price with a stop loss above the highest volume bar on the profile.
The first target is the POC of the volume profile about a 15% price drop . The second target is the pivot low on August 1st for another 15% drop.
Taking of 1/2 at each target yields an expected 23% return over a period of about 5 trading days since drops are faster than rises.
The call options of mid September have low volumes so I will not consider them.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.